Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer | Oncogene
Clinical management of metastatic colorectal cancer in the era of precision medicine - Ciardiello - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Cancers | Free Full-Text | Immune Resistance and EGFR Antagonists in Colorectal Cancer
Colorectal adenocarcinoma‐derived EGFR mutants are oncogenic and sensitive to EGFR‐targeted monoclonal antibodies, cetuximab and panitumumab - Kim - 2020 - International Journal of Cancer - Wiley Online Library
Hexameric procyanidins inhibit colorectal cancer cell growth through both redox and non-redox regulation of the epidermal growth factor signaling pathway - ScienceDirect
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
APMG Colon Molecular Pathways
Frontiers | Targeting EGFR in Esophagogastric Cancer
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution - ScienceDirect
Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells | Oncotarget
New combination therapy offers bowel cancer patients extra treatment option
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. - Abstract - Europe PMC
Biomarqueurs des cancers colorectaux utiles en pratique clinique – FMC-HGE
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer | Aging
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
Y‑box‑binding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study - The Lancet Oncology
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives - Annals of Oncology
